Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease

Fujii H, Suzuki Y, Sawada K, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: a large-scale multicenter retrospective study. Hepatol Res. 2023;53:1059–72.

Article  CAS  PubMed  Google Scholar 

Higuchi M, Tamaki N, Kurosaki M, et al. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther. 2022;55:292–301.

Article  PubMed  Google Scholar 

Nabi O, Lacombe K, Boursier J, et al. Prevalence and risk factors of nonalcoholic fatty liver disease and advanced fibrosis in general population: the French nationwide NASH-CO study. Gastroenterology. 2020;159:791-793.e2.

Article  CAS  PubMed  Google Scholar 

Nabi O, Lapidus N, Boursier J, et al. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology. 2023;78:272–83.

Article  PubMed  Google Scholar 

Sookoian S, Pirola CJ. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47:16–25.

Article  CAS  PubMed  Google Scholar 

Lu FB, Hu ED, Xu LM, et al. The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12:491–502.

Article  CAS  PubMed  Google Scholar 

Young S, Tariq R, Provenza J, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020;4:953–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito T, Ishigami M, Zou B, et al. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040. Hepatol Int. 2021;15:366–79.

Article  PubMed  Google Scholar 

Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739–52.

Article  PubMed  Google Scholar 

Leung JC, Loong TC, Wei JL, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology. 2017;65:54–64.

Article  CAS  PubMed  Google Scholar 

Zou B, Yeo YH, Nguyen VH, et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016. J Intern Med. 2020;288:139–51.

Article  CAS  PubMed  Google Scholar 

Golabi P, Paik JM, Arshad T, et al. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol Commun. 2020;4:1136–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Younes R, Govaere O, Petta S, et al. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut. 2022;71:382–90.

Article  CAS  PubMed  Google Scholar 

Hagström H, Nasr P, Ekstedt M, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2:48–57.

Article  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56.

Article  CAS  PubMed  Google Scholar 

Nakano M, Kawaguchi M, Kawaguchi T. almost identical values of various noninvasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia. J Hepatol. 2024;80:e155–7.

Article  PubMed  Google Scholar 

Nagai K, Tanaka T, Kodaira N, et al. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22:118–27.

Article  PubMed  PubMed Central  Google Scholar 

Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.

Article  PubMed  PubMed Central  Google Scholar 

Mori K, Tanaka M, Higashiura Y, et al. High fatty liver index is an independent predictor of ischemic heart disease during a 10-year period in a Japanese population. Hepatol Res. 2022;52:687–98.

Article  CAS  PubMed  Google Scholar 

Koehler EM, Schouten JN, Hansen BE, et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11:1201–4.

Article  PubMed  Google Scholar 

Fujihara K, Yamada-Harada M, Matsubayashi Y, et al. Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf. 2021;30:594–601.

Article  PubMed  Google Scholar 

Spreeuwenberg MD, Bartak A, Croon MA, et al. The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health. Med Care. 2010;48:166–74.

Article  PubMed  Google Scholar 

Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44–8.

Article  CAS  PubMed  Google Scholar 

Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012. J Gastroenterol. 2015;50:95–108.

Article  CAS  PubMed  Google Scholar 

Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51:1593–602.

Article  CAS  PubMed  Google Scholar 

Tang A, Ng CH, Phang PH, et al. Comparative burden of metabolic dysfunction in lean NAFLD vs. non-lean NAFLD—a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:1750-1760.e12.

Article  CAS  PubMed  Google Scholar 

Ishido S, Tamaki N, Takahashi Y, et al. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease. BMC Gastroenterol. 2023;23:211.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ha J, Yim SY, Karagozian R. Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:2496-2507.e5.

Article  PubMed  Google Scholar 

Chang Y, Cho YK, Cho J, et al. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study. Am J Gastroenterol. 2019;114:620–9.

Article  PubMed  Google Scholar 

Karagozian R, Bhardwaj G, Wakefield DB, et al. Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis. Liver Int. 2016;36:1450–6.

Article  PubMed  Google Scholar 

Kim D, Wijarnpreecha K, Sandhu KK, et al. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41:1832–40.

Article  CAS  PubMed  Google Scholar 

Kawanaka M, Nishino K, Kawada M, et al. Lean nonalcoholic fatty liver disease: age-dependent differences in pathology, prognosis, and liver-related events. Hepatol Res. 2023;53:829–43.

Article  CAS  PubMed  Google Scholar 

Iwaki M, Kobayashi T, Nogami A, et al. Impact of sarcopenia on non-alcoholic fatty liver disease. Nutrients. 2023;15:891.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasutake K, Nakamuta M, Shima Y, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44:471–7.

Article  CAS  PubMed  Google Scholar 

Ajmera V, Liu A, Bettencourt R, et al. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Aliment Pharmacol Ther. 2021;54:68–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vilarinho S, Ajmera V, Zheng M, et al. Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD. Hepatology. 2021;74:2241–50.

Article  PubMed  Google Scholar 

Yip TC, Vilar-Gomez E, Petta S, et al. Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology. 2023;77:1404–27.

Article  PubMed  Google Scholar 

Tamaki N, Ahlholm N, Luukkonen PK, et al. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022;132:e162513.

Article 

留言 (0)

沒有登入
gif